George’s triple therapy for hypertension hits mark in stroke

George’s triple therapy for hypertension hits mark in stroke

George Medicines’ recently-approved high blood pressure therapy Widaplik could offer a desperately needed new treatment for patients with intracerebral haemorrhage (ICH), the most severe form of stroke. An investigator-led study reported this week at the World Stroke Congress in Barcelona has shown that Widaplik (also known as GMRx2), a single-tablet combination comprising low doses of…

Read More
AZ chalks up another positive trial for hypertension drug

AZ chalks up another positive trial for hypertension drug

AstraZeneca’s baxdrostat has hit the mark in another phase 3 trial involving people who struggle to control their blood pressure with current therapies, keeping the would-be blockbuster on track for regulatory filings this year. The latest top-line readout from the Bax24 study in patients with resistant hypertension showed that baxdrostat achieved a statistically significant reduction…

Read More